These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

878 related items for PubMed ID: 27037651

  • 1. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
    Young PG, Rubin J, Angarone M, Flaherty J, Penugonda S, Stosor V, Ison MG.
    Transpl Infect Dis; 2016 Jun; 18(3):390-5. PubMed ID: 27037651
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Bruminhent J, Rotjanapan P, Watcharananan SP.
    Transplant Proc; 2017 Jun; 49(5):1048-1052. PubMed ID: 28583524
    [Abstract] [Full Text] [Related]

  • 3. Resistant cytomegalovirus in intestinal and multivisceral transplant recipients.
    Timpone JG, Yimen M, Cox S, Teran R, Ajluni S, Goldstein D, Fishbein T, Kumar PN, Matsumoto C.
    Transpl Infect Dis; 2016 Apr; 18(2):202-9. PubMed ID: 26853894
    [Abstract] [Full Text] [Related]

  • 4. Resistant Cytomegalovirus Infection in Solid-organ Transplantation: Single-center Experience, Literature Review of Risk Factors, and Proposed Preventive Strategies.
    Majeed A, Latif A, Kapoor V, Sohail A, Florita C, Georgescu A, Zangeneh T.
    Transplant Proc; 2018 Dec; 50(10):3756-3762. PubMed ID: 30586840
    [Abstract] [Full Text] [Related]

  • 5. Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients.
    Gagermeier JP, Rusinak JD, Lurain NS, Alex CG, Dilling DF, Wigfield CH, Love RB.
    Transpl Infect Dis; 2014 Dec; 16(6):941-50. PubMed ID: 25491023
    [Abstract] [Full Text] [Related]

  • 6. Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection.
    Isada CM, Yen-Lieberman B, Lurain NS, Schilz R, Kohn D, Longworth DL, Taege AJ, Mossad SB, Maurer J, Flechner SM, Mawhorter SD, Braun W, Gordon SM, Schmitt SK, Goldman M, Long J, Haug M, Avery RK.
    Transpl Infect Dis; 2002 Dec; 4(4):189-94. PubMed ID: 12535261
    [Abstract] [Full Text] [Related]

  • 7. Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics.
    Caldés A, Gil-Vernet S, Armendariz Y, Colom H, Pou L, Niubó J, Lladó L, Torras J, Manito N, Rufí G, Grinyó JM.
    Transpl Infect Dis; 2010 Jun; 12(3):204-12. PubMed ID: 20002612
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D, Ogawa Y, Fujita H, Morita K, Sasaki H, Oishi Y, Higuchi H, Hatanaka K, Shinohara N.
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [Abstract] [Full Text] [Related]

  • 9. Systematic review of ganciclovir pharmacodynamics during the prevention of cytomegalovirus infection in adult solid organ transplant recipients.
    Wong DD, van Zuylen WJ, Craig ME, Rawlinson WD.
    Rev Med Virol; 2019 Mar; 29(2):e2023. PubMed ID: 30556615
    [Abstract] [Full Text] [Related]

  • 10. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G, Goyette N, Rollag H, Jardine AG, Pescovitz MD, Asberg A, Ives J, Hartmann A, Humar A.
    Antivir Ther; 2009 Mar; 14(5):697-704. PubMed ID: 19704173
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes.
    Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR.
    Clin Transplant; 2008 Mar; 22(2):162-70. PubMed ID: 18339135
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.